Join the Citalopram group to help and get support from people like you.
Citalopram News
EEG Model Predicts Response to SSRI Meds in Major Depressive Disorder
THURSDAY, Sept. 28, 2023 – For patients with major depressive disorder, an electroencephalography (EEG)-based model can predict response to selective serotonin reuptake inhibitor (SSRI) medications,...
Treating Menopause Symptoms: Medications, Lifestyle & Self-Care
MONDAY, June 19, 2023 – Navigating the changes and discomforts of menopause can be a frustrating experience for many women. Daily life can be significantly affected by symptoms ranging from hot...
The Most Common Depression Medications, Explained
FRIDAY, May 26, 2023 – You've been diagnosed with depression. What's next? The cornerstone of treatment remains antidepressants, so it's likely your doctor will prescribe one for you, but which one...
FDA Medwatch Alert: Celexa (citalopram hydrobromide) - Drug Safety Communication: Revised Recommendations, Potential Risk of Abnormal Heart Rhythms
ISSUE: FDA is clarifying dosing and warning recommendations for the antidepressant Celexa (citalopram hydrobromide; also available in generic form). In August 2011, FDA issued a Drug Safety ...
FDA Medwatch Alert: Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants: Drug Safety Communication - Use During Pregnancy and Potential Risk of Persistent Pulmonary Hypertension of the Newborn
Including Celexa (citalopram); Lexapro (escitalopram); Prozac, Sarafem, Symbyax (fluoxetine); Luvox, Luvox CR (fluvoxamine); Paxil, Paxil CR, Pexeva (paroxetine); Zoloft (sertraline); Viibryd...
FDA Medwatch Alert: Celexa (citalopram hydrobromide): Drug Safety Communication - Abnormal Heart Rhythms Associated With High Doses
ISSUE: FDA notified healthcare professionals and patients that the antidepressant Celexa (citalopram hydrobromide) should no longer be used at doses greater than 40 mg per day because it can cause...
FDA Medwatch Alert: Citalopram And Finasteride by Greenstone: Recall - Possible Mislabeling
ISSUE: Greenstone LLC announced a recall of medicines with lot number FI0510058-A on the label. Bottles labeled as Citalopram (used to treat depression) may contain Finasteride (used for the...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Anxiety and Stress, Bipolar Disorder, Agitation, Depression, Postpartum Depression, Panic Disorder, Premenstrual Dysphoric Disorder, Dysthymia, Neuralgia, Obsessive Compulsive Disorder, Hot Flashes, Generalized Anxiety Disorder, Borderline Personality Disorder